CHAPEL HILL, N.C. – Blue Cross and Blue Shield of North Carolina (BCBSNC) has announced Dr. Lisa Carey, Medical Director of the University of North Carolina at Chapel Hill (UNC) Breast Center and Associate Director of UNC Lineberger Comprehensive Cancer Center, as the newest member of its board of trustees.
Chapel Hill, NC – Multiple research projects – including a 2006 study conducted at the University of North Carolina at Chapel Hill – have used DNA microarray analysis to identify several breast cancer subtypes, including luminal A, luminal B, basal-like and HER2-enriched. Simple tests are being developed to help doctors identify these subtypes and to treat their patients in a more biologically-based way. In turn, these tests have made several studies possible that indicate that basal-like, or triple negative breast cancer, is more prevalent in African Americans than their Caucasian counterparts.
Chapel Hill, NC – Does hepatitis C cause liver cancer due to inflammation associated with the disease, or does the virus interact with host cells in a different way to promote the development of cancer?
Victoria Bae-Jump, MD, PhD will serve a two-year term as a junior investigator on the Gynecologic Cancer Steering Committee of the National Cancer Institute, a member institute of the National Institutes of Health.
In the processes of treating most cancers, one of the key pieces of information is the appearance of the tumor under the microscope using a technique called light microscopy. In lung cancer, for example, the appearance of the tumor determines both which chemotherapies are safe and which chemotherapies are effective. In addition, tumor appearance also suggests which patients should be tested for mutations that can be targeted by some of the most effective and safest drugs on the market.
Chapel Hill, NC – Norman E. “Ned” Sharpless, MD, professor of medicine and genetics and Associate Director for Translational Research at UNC Lineberger Comprehensive Cancer Center has been appointed the Wellcome Distinguished Professor in Cancer Research. The professorship was established by the School of Medicine in 1988 with gifts from the Burroughs Wellcome Fund and the William A. Smith Trust of Wadesboro, NC. The gifts were supplemented by the state of North Carolina the Distinguished Professors Endowment Trust Fund to create the endowed professorship.
The finding presents a possible explanation for why so many cancers possess not just genomic instability, but also more or less than the usual 46 DNA-containing chromosomes.
Chapel Hill, NC – Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
Chapel Hill - Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy.
Chapel Hill, NC – Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for many patients.
Chapel Hill, NC –A medical procedure called allogeneic hematopoietic cell transplantation, commonly known as a bone marrow or stem cell transplant, is the only known curative option for many patients with life-threatening blood-borne cancers such as leukemia and lymphoma.
Idoia Garcia, PhD, a postdoctoral fellow in the lab of Timothy Gershon, MD, PhD, has been awarded a Department of Defense Visionary Postdoctoral Fellowship Award. The peer-reviewed award is intended to support exceptionally talented recent medical or other doctoral graduates in their pursuit of cutting-edge, innovative, high-risk/high-impact cancer research during their postdoctoral fellowship.
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.
American and Spanish researchers report potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests.
Which treatment for prostate cancer is most effective? Will a specific combination of cancer drugs increase patient survival for colon cancer? As the pace of scientific discovery continues to accelerate, patients and their providers face more choices and decisions about how to address their health care needs, and information that can help inform their decisions is often hard to find.
Dr. Joseph DeSimone, PhD, Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, has been elected into the National Academy of Sciences, one of the highest honors that a U.S. scientist or engineer can receive.
Embryonic stem cells are primed to kill themselves if damage to their DNA makes them a threat to the developing embryo. UNC researchers reveal how they do it.
Matthew Milowsky, MD, was recently quoted in the online journal Health News Digest on new therapies for bladder cancer.
Joseph S. Pagano, MD, has been awarded the fifth annual Hyman L. Battle Distinguished Cancer Research Award in recognition of his accomplishments in cancer research. Dr. Pagano is the director emeritus of UNC Lineberger Comprehensive Cancer Center.
Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach.
UNC Lineberger’s 36th annual scientific symposium drew large crowds, with over 450 participants.
UNC’s Seth Noar examines intersection of technology and health
Paul Armistead, MD, PhD, has received a grant of more than $396,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study leukemia stem cell-associated minor histocompatibility antigens.
UNC junior Molly DeCristo attended her first international scientific meeting, but not just as a participant. The American Association for Cancer Research (AACR) honored her poster with a rosette, judging it as “highly rated,” among the top 2.5 percent of those submitted.
A Wayne County woman doesn’t let cancer, its treatment or its recurrence get in the way of her plans to attend her oldest granddaughter’s high school graduation or her own 45th high school reunion.
Chapel Hill - A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, according to a study published in the April 18, 2012 issue of the Journal of the American Medical Association. In 2012, approximately 241,740 American men will be diagnosed with prostate cancer.
CHAPEL HILL, N.C. - As the number of breast cancer survivors increases, now estimated at 2.8 million, more will be living with the chronic effects of cancer treatments or with advanced disease.
James Coghill, MD, has received a grant of more than $529,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study a promising target for new therapies to combat graft versus host disease, a serious complication of treatment for many blood cancers.
National Cancer Institute-designated cancer centers should lead the way
Chapel Hill, NC – In a paper published today in the journal Nature Methods, a team from the University of North Carolina at Chapel Hill demonstrates a simple, cost-effective technique for three-dimensional RNA structure prediction that will help scientists understand the structures, and ultimately the functions, of the RNA molecules that dictate almost every aspect of human cell behavior. When cell behavior goes wrong, diseases – including cancer and metabolic disorders – can be the result.
Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.
Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.
UNC Health Care will offer free screenings during Oral, Head and Neck Cancer Awareness Week, on Wednesday, April 25, from 1 - 4 p.m. in the Ear, Nose, & Throat Clinic on the ground floor of the N.C. Neurosciences Hospital.
Chapel Hill, NC – In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases “en masse”, enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies.
Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting
Nancy DeMore, MD, and colleagues presented an abstract at the recent Society of Surgical Oncology 65th annual cancer symposium held in Orlando, Florida in March. Dr. DeMore is an associate professor of surgery and a member of UNC Lineberger.
UNC Cancer Care’s neuro-oncology program will recognize Ependymoma Awareness Day on April 19th, as part of the program’s overall efforts to increase public awareness of this rare tumor and the need for clinical studies to improve early diagnosis, standardize treatment and improve the health status of those living with this disease.
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in recent articles in The News & Observer and the Scientific American blog.
UNC-led team offers clinical, research agenda
Chapel Hill - In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit.
UNC Lineberger faculty members Ned Sharpless, MD, and Adam Zanation, MD, were honored for their achievements by Triangle Business Journal as 2012 Health Care Heroes.
David Ollila, MD, and Craig Burkhart, MD, spoke about teenage tanning bed use at a Child Fatality Task Force committee meeting on March 26, 2012. They discussed the option of banning teenagers below the age of 18 from tanning bed use.
The Lustgarten Foundation, the nation’s largest foundation dedicated solely to funding pancreatic cancer research, has awarded Channing Der, PhD, a $1.165 million grant to identify promising drug combinations for potential future use in clinical trials.
A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.
John Baron, MD, was interviewed by Charles Bankhead of MedPage Today on March 21, 2012 to give his perspective on three recently published reviews in "The Lancet" and "The Lancet Oncology." The reviews suggest that "regular aspirin use leads to significant reductions in the risk of cancer, metastasis, and cancer mortality."
Jared Weiss, MD, gave a podcast titled "2011 Highlights in Lung Cancer" that was posted on cancergrace.org on March 15, 2012. In the podcast, Dr. Weiss talks about highlights in lung cancer from 2011 and also answers questions.
Internationally renowned virologist; past president of national cancer and international virology associations; National Academy of Science Institute of Medicine member; North Carolina Award for Science winner; revered mentor to faculty, fellows, medical and graduate students; Berryhill Lecturer; proud grandfather; dedicated squash and tennis player; and recent honoree at his eightieth birthday.
N.E.D. is a rock band. The members of the band are gynecologic cancer surgeons from all over the country and two of them, Dr. John Boggess and Dr. John Soper, work here at UNC Health Care.
Drs. Christine E. Kistler and Adam Goldstein discuss how clinicians can better have conversations about the balance between short-term risk of adverse cardiovascular events associated with taking Chantix compared to the long-term reduction in the risk of death that results from smoking cessation.
Enduring subtle, insidious acts of racial discrimination is enough to depress anyone, but African-American men who believe that they should respond to stress with stoicism and emotional control experience more depression symptoms, according to new findings from the University of North Carolina at Chapel Hill.
A study of cervical cancer incidence and mortality in North Carolina has revealed areas where rates are unusually high.
Small DNA circles found outside the chromosomes in mammalian cells and tissues, including human cells
CHAPEL HILL, N.C. – Researchers from the University of North Carolina at Chapel Hill have helped identify a new DNA entity in mammalian cells and provided evidence that their generation leaves behind deletions in different locations of the cells’ genetic program, or genome.
The Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill has received a contract from SAIC-Frederick, Inc. to develop potential drug leads for treating renal cell carcinoma, the most common type of kidney cancer in adults.
Tobacco companies have enlisted convenience stores as their most important partners in marketing tobacco products and fighting policies that reduce tobacco use, according to a report released today by leading public health organizations, including The University of North Carolina Gillings School of Global Public Health.
Timothy Gershon, MD, PhD, assistant professor of neurology, has received a four-year National Institutes of Health Mentored Clinical Scientist Research Career Development Award grant from the National Institute of Neurologic Disease and Stroke.
CHAPEL HILL -- A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
This award, initiated by the AUA Residents Committee and approved by the AUA Board, is presented annually to recognize an outstanding urology educator or program director who has dedicated a portion of his/her career to teaching residents and advancing urology graduate medical education.
Loretta Muss, Coordinator of the N.C. Cancer Hospital Patient and Family Advisory Board, and fellow board member, Ryan Keith, talked about cancer care & families on the February 25, 26, and 27 broadcasts of YOUR HEALTH®.
Chapel Hill, NC – In a paper published today in the journal, Cell, a team from the University of North Carolina at Chapel Hill has explained for the first time how a long-studied protein complex affects cell migration and how external cues affect cell’s ability to migrate.
UNC Lineberger patient David Alston talks about the treatment he is undergoing for testicular cancer.
The story "Men find emotional support on hospital bathroom's dry erase board" aired on February 23, 2012 on WRAL.
The story "Shortages Of Life-Saving Drugs Getting Worse" aired today on WFAE 90.7, Charlotte's NPR news source.
UNC Lineberger’s Carolina Well and the Comprehensive Cancer Support Program (CCSP) offered a workshop on “Cancer Transitions: Promoting Wellness & Group Process” for community outreach coordinators and their community partners as well for interested UNC nurses and staff.
Chapel Hill, NC – A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross – a “library” of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.
Training the next generation of scientists is vital to continued progress in understanding cancer and all human disease. But how do students evaluate the programs offered by colleges and universities to decide which program is the best fit for them?
Making a simple substitution of water or diet soft drinks for drinks with calories can help people lose four to five pounds, a new University of North Carolina at Chapel Hill study shows.
Super Bowl Sunday was super for another reason.
A new online resource is available to help connect women and adolescents to life-saving cervical cancer-related services.
Scientists from UNC Lineberger have published a report describing an outreach program they developed for breast cancer survivors in four NC counties.
First cases in Triangle done at UNC
Lawrence Marks, MD, chair of UNC's department of radiation oncology and a UNC Lineberger member, is quoted in the article "TomoTherapy offers safer radiation" published in today's issue of The News & Observer.
Becker's Hospital Review has named the N.C Cancer Hospital as one of "70 Hospitals with Great Oncology Programs."
Bladder cancer patients in the Triangle area are not alone. They have a monthly group where “true loving support for each other” is shared, says David Langham, a bladder cancer survivor and one of the organizers of the group.
UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded
The way tobacco products are marketed and sold changed with the June 2009 passage of the Family Smoking Prevention and Tobacco Control Act. For example, this law mandates larger and stronger warning labels on packs and advertising and prohibits the sale of “light” and clove cigarettes. The FDA Act also now allows states and local communities to regulate the time, place, and manner of tobacco advertising. Thus, states could restrict tobacco promotions or restrict the location of tobacco advertising.
In 2008 UNC and Harvard University’s Brigham and Women’s Hospital in Boston were selected by the U.S. Agency for Healthcare Research and Quality to carry out accelerated practical studies examining the comparative effectiveness of cancer treatments. The collaboration is called the Cancer Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Comparative Effectiveness Consortium.
When Chase Jones organized Basebald for the Cure, he hit a home run!
As part of Patient Power® coverage of the annual meeting of the American Society of Hematology (ASH), UNC Lineberger member Steven Park, MD, talks about the latest in treatment for Hodgkin Lymphoma.
Coca-Cola and Tar Heel Athletics team up to help cancer research and treatment.
Whether photographing a child in the streets of Vietnam or consulting with a patient about a diagnosis, Dr. Paul Godley employs his intuition and charming personality to put the person in front of him at ease within a matter of moments.
UNC radiation oncologists co-author Journal of Clinical Oncology editorial on breast cancer radiotherapy and coronary artery stenosis
Timothy Zagar, MD, assistant professor of radiation oncology, and Lawrence Marks, MD, professor and chair of radiation oncology, co-authored an editorial in the December 27, 2011 issue of the Journal of Clinical Oncology.
UNC scientists collaborate to find first major genetic mutation associated with hereditary prostate cancer risk
Chapel Hill - After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.
Chapel Hill, NC - How much medical information does a woman understand and retain about her breast cancer diagnosis? UNC scientists participated in a four-institution study involving 440 women with early-stage breast cancer and found that breast cancer survivors had limited knowledge about their surgical options, including an understanding of something as important as the risk of recurrence.
Deborah Tate, PhD, associate professor in the Department of Health Behavior and Health Education and the Department of Nutrition at UNC-Chapel Hill, is quoted in the article "Latest gadgets give diets, workouts a high-tech boost" published in today's issue of The News & Observer.
UNC Lineberger geriatric oncology program leaders co-author Journal of Clinical Oncology editorial about older women and breast cancer
UNC Lineberger Geriatric Oncology program leaders Hy Muss, MD, and Jan Busby-Whitehead, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Muss is professor of medicine. Busby-Whitehead is professor of medicine, and director of the UNC School of Medicine’s Center for Aging and Health and Division of Geriatric Medicine.
UNC Lineberger GI Oncology program directors Joel Tepper, MD, and Bert O’Neil, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Tepper is the Hector McLean Distinguished Professor of Cancer Research. O’Neil is associate professor of medicine.
New research study examines behavioral economics of colorectal cancer screening in underserved populations
CHAPEL HILL, N.C. – A new study at UNC Chapel Hill will examine what complex and conjoined behavioral factors influence low income people to pursue colorectal cancer screening and what strategies could increase screening rates in disadvantaged communities.
Nancy E. Thomas, MD, PhD, was appointed the first Irene and Robert Alan Briggaman Distinguished Professor. The professorship is named in honor of Dr. Briggaman, who served as chair of the UNC Department of Dermatology from 1987-1999, and his wife, Irene.
Ruben Gonzalez-Crespo, a Spanish interpreter at UNC Lineberger Comprehensive Cancer Center, was highlighted in the November 2011 issue of the University Gazette in an article titled "Former singer finds new voice helping others battle cancer."
Mechanism explains how virus survives in the liver and how a new antiviral works
The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) will award 20 oncology trainees with Merit Awards at the 2012 Genitourinary Cancers Symposium. The symposium will be held February 2 - 4, 2012 in San Francisco.
Tori Frahm has experienced just eight Christmases, but she epitomizes the true spirit of the holiday. She and her family organized collection and delivery of 750 presents for pediatric oncology patients and their siblings at UNC Lineberger Comprehensive Cancer Center. The gifts helped 125 families have a brighter holiday.
One neighborhood in Cary has become the centerpiece of a holiday tradition that benefits UNC Lineberger.
Chapel Hill, NC – In an editorial published today in the Journal of Clinical Oncology, UNC associate professor E. Claire Dees, MD, reviews current evidence on the safety and efficacy of combination therapies currently used for metastatic breast cancer and urges clinical researchers to move forward with new studies that leverage advances in the identification of tumor biomarkers.
Six University of North Carolina at Chapel Hill faculty members have been named fellows of the American Association for the Advancement of Science.
Dr. Marci Campbell, professor of nutrition at the University of North Carolina Gillings School of Global Public Health, died December 14 after living with cancer with grace and caring for almost two years.
Weili Lin, PhD, has been elected a Fellow of the American Institute for Medical and Biological Engineering. Lin was cited for his outstanding contributions to the development and translation of MR functional neuroimaging.
American Cancer Society Revises Cancer Screening Guideline Process; UNC scientists are report co-authors
ATLANTA –December 13, 2011– The American Cancer Society has revised its guideline formation process to achieve greater transparency, consistency, and rigor in creating guidance about cancer screening. The new methods align with new principles from the Institutes of Medicine (IOM) by creating a single generalist group for writing the guidelines, commissioning systematic evidence reviews, and clearly articulating the benefits, limitations, and harms associated with cancer screening tests. The new process is outlined in a Special Communication in the December 14, 2011 issue of the Journal of the American Medical Association.
CHAPEL HILL – The era of widely available next generation personal genomic testing has arrived and with it the ability to quickly and relatively affordably learn the sequence of your entire genome. This would include what is referred to as the “exome,” your complete set of protein-coding sequences.
Chapel Hill - The complete sequence of an individual’s genome – all 3 billion DNA building blocks - will soon be affordably available to doctors, patients and even consumers. While knowledge of one’s genome may have important medical benefits, tremendous questions remain regarding an avalanche of such data means and how they should be used. Many clinical, ethical and social issues arise from the evaluation, use and sharing of the data.
Donald Rosenstein, MD, professor of psychiatry and medicine in the UNC School of Medicine and director of the UNC Comprehensive Cancer Support Program, will serve a one-year term as president of the Academy of Psychosomatic Medicine. Dr. Rosenstein is a member of UNC Lineberger Comprehensive Cancer Center.
President Obama has announced his intent to nominate Barbara K. Rimer, DrPH, Dean and Alumni Distinguished Professor of the University of North Carolina Gillings School of Global Public Health, to chair the President’s Cancer Panel. The panel was established as part of the National Cancer Act, signed by President Nixon in 1971
The molecule is the protein Shc (pronounced SHIK), and new blood vessel formation, or angiogenesis, is seriously impaired without it.
UNC scientists contribute cell studies and protein expression analysis
Paola Gehrig, MD, associate professor of obstetrics and gynecology, has been named director of UNC Gynecologic Oncology. In her new role she will oversee gynecologic oncology in the School of Medicine’s Department of Obstetrics and Gynecology and the UNC Lineberger Comprehensive Cancer Center.
Blossom Damania, PhD, was a speaker at the Twenty-third Annual Kavli Frontiers of Science Symposium, held November 17-19, 2011 in Irvine, California. The symposium is hosted by the National Academy of Sciences.
Protein associated with childhood cancer alters the structure of DNA, leading to cancer, UNC study shows
Chapel Hill - UNC scientists have demonstrated for the first time how a critical gene associated with a type of childhood cancer alters the way DNA is packaged in cells and leads to cancer. Their laboratory discovery could result in the development of a targeted therapy to treat Ewing Sarcoma, a malignant bone and soft tissue tumor of children and young adults.
CHAPEL HILL, N.C. – After a heart attack, the portions of the heart damaged by a lack of oxygen become scar tissue. Researchers have long sought ways to avoid this scarring, which can harden the walls of the heart, lessen its ability to pump blood throughout the body and eventually lead to heart failure. But new research from the University of North Carolina at Chapel Hill School of Medicine shows that interrupting this process can weaken heart function even further.
Chapel Hill, NC – UNC’s Biomedical Research Imaging Center (BRIC) will be the fourth site in the United States to obtain a leading-edge imaging system called an MRPET scanner (also known as a PET-MRI). The machine will first be installed in current BRIC building but will be moved to the new building going up adjacent to the UNC Lineberger Comprehensive Cancer Center, and BRIC director Weili Lin, PhD, is already strategizing with top experts in the field to put this innovative technology to good use.
UNC Lineberger and SAS developing technology that tracks patient characteristics, treatment and outcomes
Chapel Hill - The Centers for Disease Control and Prevention Advisory Committee on Immunization Practices recently recommended that teenage boys be vaccinated against the human papillomavirus.
WCHL named Dianne Shaw a Hometown Hero for November 8, 2011. Each weekday the station selects a Hometown Hero who goes “over and above the call of duty,” exemplifying excellent service and dedication to others in the community.
Ned Sharpless, MD, professor of medicine and genetics and associate director for translational research at UNC Lineberger, commented on Mayo Clinic's latest research on aging on the November 6, 2011 broadcast of the NBC Nightly News.
WCHL named Loretta Muss a Hometown Hero for November 4, 2011. Each weekday the station selects a Hometown Hero who goes “over and above the call of duty,” exemplifying excellent service and dedication to others in the community.
CHAPEL HILL, N.C. - An international team of scientists, including biologists from the University of North Carolina at Chapel Hill, may have pinpointed for the first time the mechanism responsible for cell polyploidy, a state in which cells contain more than 2 paired sets of chromosomes.
Chapel Hill - The Oncology Nursing Excellence and Clinical Services Excellence Awards recognize four employees who exemplify the very best in cancer care at UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care.
Wells Fargo Tar Heel 10 miler and Fleet Feet 4+ mile run take place April 21, 2012
Findings guide future research on chemotherapy resistance
UNC scientists offer first evidence of using biologically targeted nanoparticles to boost radiation therapy effects
Chapel Hill - Making a tumor more sensitive to radiotherapy is a primary goal of combining chemo and radiation therapy to treat many types of cancer, but with the chemotherapy drugs come unwanted side effects.
UNC surgical oncologist co-authors Lancet editorial
Chapel Hill - A UNC scientist was awarded one of seven grants presented by the Avon Walk for Breast Cancer at their seventh annual event in Charlotte, NC.
CHAPEL HILL – Research from the University of North Carolina at Chapel Hill suggests that the timing of exposure to UV rays – early in the morning or later in the afternoon – can influence the onset of skin cancer.
Cellular “mathematics” help equalize X chromosome gene expression
The V Foundation for Cancer Research announced this week that Greg Wang, PhD, has been awarded the Martin D. Abeloff, MD, V Scholar Award. This award goes to the research project that receives the highest rating from the V Foundation’s Scientific Advisory Board. Wang was tied with Hongwu Zheng, PhD, of Cold Spring Harbor Laboratory for this honor and is the 10th V Scholar from UNC Lineberger.
Joseph DeSimone, PhD, has been invited to join an elite list of speakers at this year’s TEDMED Conference in San Diego, Calif., Oct. 25 – 28.
Coach Roy Williams’ 7th annual Fast Break Against Cancer raised more than $210,000 for cancer research and treatment at UNC Lineberger and in our community.
Woody and Jean Durham were honored on October 13 in Chapel Hill for their volunteer service to UNC Lineberger Comprehensive Cancer Center at a dinner called “A Toast to Woody.”
Breast Cancer Surveillance Consortium also compares digital and film mammography
Kimryn Rathmell, MD, PhD, thrives on discovery, whether in her lab developing a new experiment for kidney cancer or in her kitchen trying out a new food or cuisine.
Terry Magnuson, PhD, Sarah Graham Kenan Professor, Chair of the Department of Genetics, and Vice Dean for Research at the School of Medicine, is featured in a spotlight story on UNC-Chapel Hill's website.
UNC-Chapel Hill Chancellor Emeritus James Moeser talks with Shelley Earp, MD, director of the UNC Lineberger Comprehensive Cancer Center, about the creation and development of the cancer center. This discussion is the third in a series based on the book "Good to Great" by Jim Collins.
Grant from the Centers for Disease Control focuses on younger breast cancer patients
UNC scientists report that in early stage, asymptomatic non-small cell lung cancer, early brain recurrences are potentially detectable prior to surgery and recommend that physicians consider including a routine pre-operative staging brain MRI. In addition, patients whose tumors are determined to be higher risk based on the findings at surgery, should consider post-operative MRI to offer early treatment of unrecognized metastasis.
Dr. Nicholas Shaheen, professor in the UNC School of Medicine, adjunct professor in the UNC Gillings School of Global Public Health and director of the UNC Center for Esophageal Diseases and Swallowing, will co-direct Barrett’s Esophagus Translational Research Network (BETRNet) projects.
Carol Shores, MD, PhD, FACS, has been interested in the link between viruses and cancer for over 20 years, after working on virus- associated cancers as a pre-doctoral fellow in the UNC Department of Biochemistry and Biophysics. Oropharyngeal cancers, like cervical cancer, are associated with human papilloma viruses and endemic Burkitt lymphoma, a childhood cancer in sub-Saharan Africa, is associated with Epstein-Barr virus.
Jian Jin, PhD, an associate professor and director of medicinal chemistry in the Center for Integrative Chemical Biology and Drug Discovery at UNC-Chapel Hill, is featured in endeavors magazine.
CHAPEL HILL, N.C. - Patients who have high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study. Their study is the first to report on multiple patients with these skin carcinomas treated simultaneously with radio-and chemotherapy.
Noel Brewer, a professor of public health at UNC who has also studied HPV vaccine use, said the public controversy has been less harmful than the fact that many doctors simply don’t know or choose not to recommend it, or that many parents have insurance plans that don’t cover the vaccine or charge large co-pays for it.
Keith Amos, MD, quoted in The Huffington Post
Chapel Hill, NC – G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Channing Der and his wife, Kathy, had already planned a 30th wedding anniversary trip to Kenya. After hearing Carolina alumnus and author Rye Barcott talk about his book, It Happened on the Way to War: A Marine’s Path to Peace, and describe the Carolina for Kibera program in Nairobi, Kenya, they knew they had to see the program in action.
Toolkit moves best practices to the community
Chapel Hill - A team of UNC scientists report that in laboratory studies, overexpression of a specific protein could be used as a prognostic marker and as a guide for therapeutic choices for patients with head and neck cancer. Their findings appear in the September 9, 2011 online issue of the journal Clinical Cancer Research.
CHAPEL HILL – When sperm meets egg, the chemical instructions that tag sperm cells must be erased so that human life can start anew. One way these instructions are erased is through demethylation, the removal of specific chemical tags or methyl groups that dot the underlying DNA of cells. Though scientists have known about this phenomenon for a decade, exactly how such “reprogramming” occurs has proved elusive.
CHAPEL HILL, N.C. – Weili Lin, PhD, professor of radiology, neurology and biomedical engineering and director of the UNC Biomedical Research Imaging Center, has been appointed The Dixie Lee Boney Soo Distinguished Professor in Neurological Medicine.
Chapel Hill - A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor of Chemistry and Pharmacy, and colleagues report their finding online in advance of print on September 14, 2011 in Angewandte Chemie, the German-based flagship chemistry journal.
CHAPEL HILL – A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person’s risk of schizophrenia and bipolar disorder.
CHAPEL HILL – Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body’s own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.
Two recent grants from the National Science Foundation will support soft matter research at the University of North Carolina at Chapel Hill.
Seventh annual event benefits cancer research and treatment in our community
Kevin Weeks, a chemist at the University of North Carolina at Chapel Hill, has received an award from the National Institutes of Health to support innovative research on creating new drugs that work by binding to RNA.
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.
Two UNC Lineberger faculty, Noel Brewer, PhD, associate professor of health behavior and health education in the UNC Gillings School of Global Public Health, and Karen Mohlke, PhD, associate professor of genetics in the UNC School of Medicine, have received the 2011 Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty at UNC-Chapel Hill.
Chapel Hill - Deciding whether or not to have breast reconstruction after mastectomy is highly challenging for many patients. Clara Lee, MD, MPP, a UNC School of Medicine physician/scientist, has received a five-year grant award to examine patients’ decision-making process about reconstruction and the effects of reconstruction on quality of life and body image. The $862,700.00 career development award to the plastic and reconstructive surgeon is from the National Institutes of Health.
Peer Connect provides training for cancer survivors who wish to "give back" by talking with or being a buddy to another patient or survivor. Peer Connect meets a need for more formalized training for the "guides" or peer counselors by teaching effective communication skills and strategies based on Motivational Interviewing (MI), which focuses on listening and meeting the needs of the recipient rather than giving advice or telling people what to do.
Chapel Hill, NC – Lawrence B. Marks, MD, chairman of the UNC Department of Radiation Oncology, has been appointed the Dr. Sidney K. Simon Distinguished Professor of Oncology Research at UNC-Chapel Hill. The professorship, established by a $500K gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas, is named in honor of Mr. Loewenbaum’s grandfather, Dr. Sidney K. Simon.
Wizdom Powell Hammond, PhD, assistant professor of health behavior and health education at UNC Gillings School of Global Public Health, has been named to the 2011-2012 class of White House Fellows, the White House recently announced.
Susan McKenney, APRN, BC, MSN, OCN, Clinical Associate Professor of Surgery, has been selected by NBC 17, along with Chapel Hill and Durham magazines, as a Super 17 Nurse.
Chapel Hill, NC – Stefanie Sarantopoulos, MD, PhD, was recruited to UNC in 2009 with the help of the University Cancer Research Fund. Now she is a recipient of two grants that have helped establish her own laboratory to look into the causes of chronic Graft vs. Host Disease. Sarantopoulos is an Assistant Professor of Medicine in the Division of Hematology/Oncology and Microbiology and Immunology and a member of UNC Lineberger Comprehensive Cancer Center.
Hyundai Hope on Wheels and Raleigh-Durham Area Hyundai Dealers today awarded Ian Davis, MD, PhD, a $100,000 grant to support research into the causes of and treatments for pediatric sarcoma. Davis, assistant professor of pediatrics and genetics and a member of UNC Lineberger Comprehensive Cancer Center is one of 71 recipients of Hyundai Hope on Wheels’ 2011 Hope Grant program, where $7.1 million will be awarded to support research and programs in honor of National Childhood Cancer Awareness Month.
Men who are 40 years old or older, or who have a family history of prostate cancer, may make an appointment in advance by calling 919-966-1316. Walk-ins are also accepted.
Close to 40 participants braved Hurricane Irene to learn how to be effective advocates for lung cancer.
The UNC Comprehensive Cancer Support Program is sponsoring a monthly community educational series called “Cancer Conversations.” Featuring UNC physicians and others, the series is a time intended to help people learn from and talk with cancer experts. The sessions will be held the third Tuesday of each month from 7:00 – 8:30 pm: September 20, October 18, November 15 (no session in December).
CHAPEL HILL, N.C. It takes life-saving research to Conquer Kids’ Cancer! The St. Baldrick’s Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, has awarded a $330,000 St. Baldrick’s Scholar award to Timothy Gershon, MD, PhD, and assistant professor of neurology at the School of Medicine at the University of North Carolina at Chapel Hill.
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.
Causes of African-American breast cancer incidence study receives $19.3M: UNC partners to form largest US database
Chapel Hill - UNC scientist Robert Millikan will partner with Christine Ambrosone, of Roswell Park Cancer Institute, and Julie R. Palmer, of Boston University, in the most ambitious study to date of breast cancer among younger African-American women.
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, is quoted in the Health section of USA Today's website.
A grant from The V Foundation for Cancer Research is helping to fund skin cancer research at UNC Lineberger.
Proteins made by cancer cells focus of effort
Each month the Patient Resource Cancer Guide recognizes an oncology nurse who exhibits dedication and compassion for his/her patients and profession - Delma Armstrong, BSN, RN, OCN, is the featured oncology nurse for June 2011.
An expert interview with Laura Linnan, ScD, CHES, is featured in News & Views, a publication of the Wellness Council of America (WELCOA).
Charles Perou, PhD, appointed May Goldman Shaw Distinguished Professorship of Molecular Oncology Research
Chapel Hill, NC – Charles M. Perou, PhD, professor of genetics, and pathology & laboratory medicine, and leader of the UNC Lineberger Comprehensive Cancer Center breast cancer research program has been appointed the May Goldman Shaw Distinguished Professor of Molecular Oncology Research. The professorship, established by a $1 million gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas is named in honor of Mrs. Lowenbaum’s mother, May Goldman Shaw.
Chapel Hill - University of North Carolina at Chapel Hill researcher Joseph DeSimone, PhD, will partner with scientists at two universities and a local biotechnology company to develop a nanoparticle vaccine for prostate cancer. The Prostate Cancer Foundation awarded the UNC-Beth Israel Deaconess Medical Center/Harvard-Johns Hopkins-Liquidia Technologies consortium a Challenge Award of $1 million, one of ten such awards funded by the organization.
New television ads for UNC Cancer Care are now airing. As we launch the UNC Cancer Care brand, we hope these ads reflect a little bit of what our outstanding clinical care programs are all about. Be sure to look for them on television! The ads can also be viewed below.
CHAPEL HILL, NC – In a kind of molecular gymnastics, scientists at the University of North Carolina at Chapel Hill School of Medicine have devised a gene therapy cocktail that has the potential to treat some inherited diseases associated with “misfolded” proteins.
Cancer is a leading cause of widowed fatherhood in the United States. Faculty with UNC Lineberger Comprehensive Cancer Center’s Comprehensive Cancer Support Program authored a commentary titled “Single Fatherhood Due to Cancer” in the August issue of the journal Psycho-Oncology outlining challenges these fathers face and future directions to develop supportive interventions for them and their children.
Six new residents have begun their training with the UNC Department of Radiation Oncology.
Stephan Moll, MD, is quoted in an article titled "Blood Clots Pose Threat to All of Us," published today on Fox Business' website.
Karyn Stitzenberg, MD, MPH, is quoted in an article titled "Tracking the Rise of Robotic Surgery for Prostate Cancer" published in the August 9, 2011 issue of the NCI Cancer Bulletin.
Angelique Whitehurst, PhD, and her Stand Up to Cancer research grant were featured in an article in the August 2011 issue of Nature Medicine.
Marci Campbell, PhD, MPH, RD, authored a guest editorial titled "Cancer is a Team Sport" for the August 2011 issue of the Clinical Journal of Oncology Nursing.
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, talks with Kristy Villa, one of the hosts of Lifetime Television’s “The Balancing Act" about colon cancer.
Chapel Hill, NC – Lisa A. Carey, MD, Professor of Medicine, Medical Director of the UNC Breast Center and Associate Director for Clinical Research at UNC Lineberger Comprehensive Cancer Center has been appointed The Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research.
Discovery may have implications for many diseases
Project will assess needs and work to accelerate adoption of evidence-based cancer prevention interventions
RALEIGH, NC – Crown Imports announced today that the highly successful “Corona Cares” charitable donation program in North Carolina will kick off on August 1 to benefit patients and families at the N.C. Cancer Hospital.
Male circumcision lowers prevalence of penile precancerous lesions among African men, UNC study finds
Chapel Hill - A University of North Carolina-led international study shows that among Kenyan men, circumcision is associated with a lower prevalence of human papillomavirus-associated precancerous lesions of the penis.
The article "Oncologists by day, rock stars by night” written by Rachel Saslow and published in The Washington Post on July 25, 2011 features the band, N.E.D (which stands for “No Evidence of Disease”).
Ken Jacobson, PhD, Kenan Professor of Cell and Developmental Biology in the UNC School of Medicine, received the Gregorio Weber Award for Excellence in Fluorescence Theory and Applications at the annual meeting of the Biophysical Society in Baltimore, Maryland.
Taking a look at telemedicine: program director talks about how it’s helping to fulfill UNC Lineberger’s mission
CHAPEL HILL, N.C. – The article "Telemedicine: Know why you're doing it " published online July 21, 2011 in Cardiovascular Business highlights the use of telemedicine at the N.C. Cancer Hospital.
CHAPEL HILL – For decades, scientists have known that DNA consists of four basic units – adenine, guanine, thymine and cytosine. Those four bases have been taught in science textbooks and have formed the basis of the growing knowledge regarding how genes code for life. Yet in recent history, scientists have expanded that list from four to six.
Collaboration between University of North Carolina at Chapel Hill and Canadian scientists has resulted in a molecular probe capable of specifically targeting two proteins that affect a wide range of biological functions in humans by controlling the expression of certain genes.
Chapel Hill, NC - Robert Adams, EdD, RT, CMD; Bahjat Qaqish, MD, PhD; and Jessica A. Church, BS, RT, all from UNC, and Kimberly L. MetCalf, EdD, RT, MR, from the Massachusetts General Hospital Institute of Health Professions are the winners of the 2010-2011 Jean I. Widger Distinguished Author Award from the American Society of Radiologic Technologists.
Using a patient’s genetic information can be successfully used to manage the drug concentrations of tamoxifen, a drug used to treat and prevent breast cancer.
Six new fellows have joined the Division of Hematology/Oncology.
Chapel Hill - A new fellowship training program in psychosomatic medicine is beginning at UNC, a partnership of the UNC School of Medicine Department of Psychiatry and the UNC Comprehensive Cancer Support Program, part of UNC Lineberger Comprehensive Cancer Center.
Chapel Hill - Channing Der, PhD, Kenan Professor of Pharmacology, and Yue Xiong, PhD, Kenan Professor of Biochemistry and Biophysics, have been awarded the fourth annual Hyman L. Battle Distinguished Cancer Research Award in recognition of their accomplishments in cancer research. Both are members of UNC Lineberger Comprehensive Cancer Center.
American life expectancies, which have climbed steadily for almost a century, may drop in years to come as the obesity epidemic progresses.
Technology used to promote better health and cancer prevention statewide
Chapel Hill - Thomas Shea, MD, will serve a two-year term as chair of the Scientific Advisory Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR). He was previously elected as chair-elect. The Advisory Committee establishes policy for, and provides scientific direction to the CIBMTR.
UNC completes miRNA and array analysis
Recent UNC-Chapel Hill graduate and former UNC Women’s Basketball player Jessica Breland – who now plays in the WNBA for the New York Liberty – was honored with the the 23rd annual Honda Inspiration Award.
Chapel Hill - The human immune system is a double-edged sword. While it is finely adapted to fighting potentially deadly viruses, such as the H1N1 influenza, the mechanisms it uses to fight pathogens can have negative effects such as inflammatory disorders or autoimmune diseases.
Chapel Hill - UNC Lineberger Comprehensive Cancer Center honored three clinical oncology fellows with $5,000 awards for their research accomplishments and clinical excellence. These first-ever awards were given to Daniel Higginson, MD, Autumn McRee, MD, and Emma Rossi, MD.
New drugs should work for rare blood disorder
Gary Rosson was honored by the NC Triangle Komen Race for the Cure as the 2011 winner of the Co-Survivor Award. Rosson is a research associate in the lab of UNC Lineberger faculty member Scott Bultman.
Finding points new direction for study of chronic Hepatitis C
Dr. Shelley Earp, UNC Lineberger Comprehensive Cancer Center director, joined Nick Valvano, CEO of The V Foundation for Cancer Research, on ABC 11’s Heart of Carolina Perspectives show which aired on Sunday, June 19, 2011.
Input sought from Fayetteville’s African-American and Latino communities
Each year, the President’s Cancer Panel assembles a group of experts to provide official testimony about the nation’s cancer agenda. The theme changes annually – for 2009-2010 the panel focused on “America’s Demographic and Cultural Transformation: Implications for Cancer.” A full report was released this spring.
2011 Statesman Award honors extraordinary voluntary efforts
UNC Lineberger’s Fellowship Program in Hematology/Oncology is being recognized by the American Society of Clinical Oncology (ASCO) this weekend at the organization’s annual meeting in Chicago, Illinois.
CHAPEL HILL, N.C. - The article "Why do men die earlier?" written by Bridget Murray-Law and published in the June 2011 issue of Monitor on Psychology, looks at new research that analyzes how men take care of themselves.
Dr. Stuart Gold is division chief of UNC Lineberger's pediatric hematology and oncology program.
LIVESTRONG® Survivorship Center of Excellence Network to Host Landmark Meeting on Survivorship Care and Advocacy in Response to 2011 Report Findings
Conference will be held in Washington, D.C., Sept. 15-16. UNC Lineberger Comprehensive Cancer Center is part of a collaborative effort among leading medical institutions brought together by LIVESTRONG.
Data will help scientists worldwide design better experiments.
University Cancer Research Fund updates, record poster session highlights of 2011 scientific retreat
The sixth annual UNC Lineberger scientific retreat drew a record number of posters – 68 – for the poster session and competition – and close to 150 people for the talks and reception.
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
Tom May used to donate blood, but not often. If he had it to do over, he’d give as much as possible. But he can’t.
CHAPEL HILL, N.C. – Carol Otey, PhD talks about the hope & health that has resulted from recent pancreatic research & collaboration on the May 14, 2011 broadcast of Here's to Your Health.
Chapel Hill - When cancer patients experience medical problems, they may visit emergency departments, but how often and for what reasons, there is little data.
A University of North Carolina at Chapel Hill study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.
Innovative collaboration between physics and cell biology demonstrates pathway
CHAPEL HILL, N.C. – Dr. Carolyn Sartor discussed the “New Life After Cancer” organization on the April 28, 2011 broadcast of Here's to Your Health. Dr. Sartor is a breast cancer survivor and former Chair of Radiation Oncology at UNC.
Richard Goldberg, MD, distinguished professor and chief of the division of hematology/oncology, has been appointed to chair the 2012 Gastrointestinal Cancers Symposium Steering Committee on behalf of the American Society for Clinical Oncology (ASCO).
The 35th annual UNC Lineberger scientific symposium attracted more than 530 participants. Held at the Friday Center on April 27-28, 2011, the event featured speakers on "Cell Metabolism and Cancer."
NCCU-UNC Lineberger scientific collaboration yields new findings
Prestigious Executive Leadership in Academic Medicine Program builds pipeline of women leaders
CHAPEL HILL – Researchers at the University of North Carolina at Chapel Hill School of Medicine, after isolating normal stem cells that form the developing placenta, have given them the same properties of stem cells associated with an aggressive type of breast cancer.
Chapel Hill, NC - Samuel Cykert, MD, has received a $1.8 million five-year grant from the American Cancer Society (ACS) to study “Lung Cancer Surgery: Decisions Against Life Saving Care.”
The UNC-Mission Hospital Cancer Partnership, part of the UNC Cancer Network, welcomes Candace Cox, RN, OCN, to the program staff.
Local show features UNC Lineberger
A study of DNA rearrangements in roundworm chromosomes may offer new insight into large-scale genome duplications that occur in developing tumors.
UNC physician scientist receives National Academy of Sciences grant to develop cancer nanotechnology
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
"Tet is likely to be one of the important players for stem cell reprogramming."
Prestigious Breast Cancer Research Foundation-AACR Grant funds preclinical studies
CHAPEL HILL, N.C. - On Friday, March 11, a group of nurses gathered for a UNC Health Care Grand Rounds presentation by Jerome Schiro, RN, MN, OCN, Pat Decator, RN, BSN, OCN, and Amy De Pue, RN, BS, OCN.
UNC researchers working toward a rehabilitation road map
CHAPEL HILL, N.C. - My Colon Cancer Coach, a new website that launched this week, serves as a tool to help people diagnosed with colon cancer.
CHAPEL HILL, N.C. - The article "Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer" written by Jonathan Batchelor and published on the website cancernetwork.com on March 9, 2011 features an interview with UNC Lineberger member Lisa Carey, MD.
CHAPEL HILL, N.C. - A UNC study released this week in the Journal of Clinical Oncology finds an increasing incidence of squamous cell carcinoma of the oral tongue in young white females in the United States over the last three decades.
C.A.R.E. Behind the Chair® program scheduled for May9
CHAPEL HILL, N.C. - Federico Innocenti, MD, PhD, has been appointed associate professor of pharmacy in the UNC Eshelman School of Pharmacy. He will serve as associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger Comprehensive Cancer Center.
CHAPEL HILL, N.C. - A Triangle-based UNC spinoff company at the forefront of efforts to use nanotechnology to tackle diseases has received a $10 million investment from the Bill & Melinda Gates Foundation.
UNC Lineberger Physician Co-Author of Study of Screening Mammography in Women with Personal History of Breast Cancer
James P. Evans, MD, PhD is lead author of a commentary about the potential of genomic medicine.
Weili Lin, PhD, has been appointed Director of the UNC Biomedical Research Imaging Center (BRIC).
UNC Lineberger member Kurt Ribisl, PhD, was part of the study's research team.
Sixty physicians at the University of North Carolina Hospitals are listed in the latest version of “America’s Top Doctors,” a compilation that is published annually by Castle Connolly Medical Ltd. Of those, 32 are members of UNC Lineberger Comprehensive Cancer Center or involved in UNC Cancer Care’s multidisciplinary programs.
Richard Goldberg, MD is physician-in-chief of the N.C. Cancer Hospital and UNC Lineberger associate director of clinical research.
When the U.S. Food and Drug Administration (FDA) proposed new rules restricting outdoor tobacco advertising near schools and playgrounds in 2009, the tobacco industry argued that such rules would lead to a near complete ban on tobacco advertising in urban areas. An article in the March 2011 issue of the American Journal of Preventive Medicine shows that the effect of these rules would be less severe on businesses than the industry contends.
The article discusses Bernard’s work with the UNC Palliative Care Program and the Supportive Care Consult Service and Clinic.
Anders was chosen for her work on breast cancer brain metastases. Hoadley was selected for her contributions to the analysis of glioblastomas.
The Henry family shares the story of brothers Collin and Patrick, both diagnosed with cancer and receiving care at the N.C. Cancer Hospital.
UNC Lineberger members are involved in over 20 active startups.
It's a gene called DOT1L, and if you don't have enough of the DOT1L enzyme, you could be at risk for some types of heart disease.
Interested in starting a regular exercise program and supporting a good cause?